Perindopril 8mg Tablets
Overview
What is this medicine?
How to Use This Medicine
To get the most benefit from your medication, follow your doctor's instructions carefully. Read all the information provided with your prescription and follow the instructions closely. Take your medication at the same time every day to establish a routine. Continue taking your medication as directed by your doctor or healthcare provider, even if you start to feel better.
It's also important to stay hydrated by drinking plenty of non-caffeinated liquids, unless your doctor advises you to limit your fluid intake.
Storing and Disposing of Your Medication
To keep your medication effective and safe, store it at room temperature in a dry place, away from the bathroom. Keep all medications in a secure location, out of the reach of children and pets. When you're finished with your medication or it's expired, dispose of it properly. Do not flush it down the toilet or pour it down the drain unless instructed to do so by your doctor or pharmacist. If you're unsure about the best way to dispose of your medication, consult with your pharmacist. You may also want to check if there are any drug take-back programs in your area.
What to Do If You Miss a Dose
If you miss a dose, take it as soon as you remember. However, if it's close to the time for your next dose, skip the missed dose and resume your regular schedule. Do not take two doses at the same time or take extra doses to make up for the missed one.
Lifestyle & Tips
- Take medication exactly as prescribed, usually once daily before a meal.
- Do not stop taking the medication without consulting your doctor, even if you feel well.
- Limit alcohol intake as it can increase the blood pressure lowering effect.
- Avoid potassium supplements or salt substitutes containing potassium unless advised by your doctor.
- Maintain a healthy diet (low sodium, rich in fruits/vegetables), regular exercise, and manage stress.
- Monitor blood pressure at home as advised by your doctor.
Available Forms & Alternatives
Available Strengths:
Dosing & Administration
Adult Dosing
Condition-Specific Dosing:
Pediatric Dosing
Dose Adjustments
Renal Impairment:
Hepatic Impairment:
Pharmacology
Mechanism of Action
Pharmacokinetics
Absorption:
Distribution:
Elimination:
Pharmacodynamics
Safety & Warnings
BLACK BOX WARNING
Side Effects
Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek immediate medical attention:
Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of kidney problems, including:
+ Inability to pass urine
+ Changes in urine output
+ Blood in the urine
+ Sudden weight gain
Signs of high potassium levels, such as:
+ Abnormal heartbeat
+ Confusion
+ Weakness, lightheadedness, or dizziness
+ Feeling like passing out
+ Numbness or tingling
+ Shortness of breath
Severe dizziness or fainting
Persistent cough
Severe stomach pain
Severe nausea or vomiting
Signs of liver problems, including:
+ Dark urine
+ Fatigue
+ Decreased appetite
+ Stomach pain or upset
+ Light-colored stools
+ Vomiting
+ Yellow skin or eyes (jaundice)
Signs of infection, such as:
+ Fever
+ Chills
+ Sore throat
Other Possible Side Effects
Most people taking this medication do not experience severe side effects. However, some may occur. If you notice any of the following side effects or any other unusual symptoms, contact your doctor or seek medical attention if they bother you or do not go away:
Cough
Dizziness
Back pain
Reporting Side Effects
This is not an exhaustive list of possible side effects. If you have questions or concerns about side effects, contact your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
Seek Immediate Medical Attention If You Experience:
- Swelling of the face, lips, tongue, or throat (angioedema) - seek immediate medical attention.
- Difficulty breathing or swallowing.
- Severe dizziness or fainting.
- Persistent dry cough.
- Yellowing of the skin or eyes (jaundice).
- Signs of high potassium (muscle weakness, slow or irregular heartbeat).
- Signs of infection (fever, sore throat) - rare.
Before Using This Medicine
It is essential to inform your doctor about the following:
Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the allergic reaction you experienced, including any symptoms that occurred.
If you have a history of angioedema, a severe and potentially life-threatening reaction characterized by symptoms such as swelling of the hands, face, lips, eyes, tongue, or throat, difficulty breathing, swallowing problems, or unusual hoarseness.
If you have kidney disease, as this may affect your ability to take this medication.
If you are currently taking a medication that contains aliskiren and you also have diabetes or kidney problems.
* If you have taken a medication containing sacubitril within the last 36 hours.
This list is not exhaustive, and it is crucial to discuss all your medications, including prescription and over-the-counter drugs, natural products, and vitamins, with your doctor and pharmacist. They will help you determine if it is safe to take this medication in combination with your other medications and health conditions. Never start, stop, or adjust the dose of any medication without first consulting your doctor.
Precautions & Cautions
It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication.
Caution with Daily Activities
Until you understand how this medication affects you, avoid driving and other tasks that require alertness. To minimize the risk of dizziness or fainting, stand up slowly after sitting or lying down, and be cautious when climbing stairs.
Monitoring Your Condition
Regularly check your blood pressure as instructed by your healthcare provider. Additionally, have your blood work and other laboratory tests done as directed by your doctor.
Interactions with Other Substances
If you are taking a salt substitute containing potassium, a potassium-sparing diuretic, or a potassium product, consult with your doctor. Similarly, if you are on a low-salt or salt-free diet, discuss this with your doctor.
Over-the-Counter (OTC) Products and Interactions
If you have high blood pressure and are taking this medication, talk to your doctor before using OTC products that may increase blood pressure, such as cough or cold medications, diet pills, stimulants, non-steroidal anti-inflammatory drugs (NSAIDs) like ibuprofen or naproxen, and certain natural products or aids.
Alcohol Consumption
Discuss your alcohol consumption with your doctor before drinking.
Heat and Fluid Loss
Be cautious in hot weather or during physical activity, and drink plenty of fluids to prevent dehydration. If you experience excessive sweating, fluid loss, vomiting, or diarrhea, inform your doctor, as these conditions may lead to low blood pressure.
Effectiveness in Black Patients
This medication may be less effective in lowering blood pressure in Black patients. In some cases, another medication may be necessary in conjunction with this drug. If you have questions, consult with your doctor.
Risk of Angioedema
A severe and potentially life-threatening reaction called angioedema has been reported. The risk of angioedema may be higher in Black patients.
Special Considerations
If you are 65 or older, use this medication with caution, as you may be more susceptible to side effects. If you are breastfeeding, discuss the potential risks to your baby with your doctor.
Overdose Information
Overdose Symptoms:
- Severe hypotension (low blood pressure)
- Shock
- Stupor
- Bradycardia (slow heart rate)
- Electrolyte disturbances (e.g., hyperkalemia)
- Renal failure
What to Do:
Call 911 or Poison Control (1-800-222-1222) immediately. Treatment is supportive, including intravenous fluids for hypotension, and potentially hemodialysis to remove perindoprilat.
Drug Interactions
Contraindicated Interactions
- Aliskiren (in patients with diabetes or renal impairment (GFR <60 mL/min/1.73 m²))
- Sacubitril/valsartan (Entresto) - concomitant use or within 36 hours of perindopril
Major Interactions
- Potassium-sparing diuretics (e.g., spironolactone, triamterene, amiloride)
- Potassium supplements
- Lithium
- NSAIDs (Non-Steroidal Anti-Inflammatory Drugs) - including selective COX-2 inhibitors
- mTOR inhibitors (e.g., sirolimus, everolimus, temsirolimus)
- Neprilysin inhibitors (e.g., sacubitril)
Moderate Interactions
- Diuretics (thiazide or loop) - may cause excessive hypotension
- Other antihypertensives (e.g., beta-blockers, calcium channel blockers) - additive hypotensive effect
- Antidiabetic agents (insulin, oral hypoglycemics) - increased risk of hypoglycemia
- Allopurinol - increased risk of hypersensitivity reactions
- Immunosuppressants (e.g., azathioprine, cyclosporine) - increased risk of hematologic effects
- Gold (parenteral) - nitritoid reactions (facial flushing, nausea, vomiting, hypotension)
Minor Interactions
- Alcohol - additive hypotensive effect
- Antacids - may decrease bioavailability (separate administration)
Monitoring
Baseline Monitoring
Rationale: To establish baseline and guide initial dosing.
Timing: Prior to initiation
Rationale: To assess baseline renal function, as ACE inhibitors can affect kidney function.
Timing: Prior to initiation
Rationale: To assess baseline potassium levels, as ACE inhibitors can cause hyperkalemia.
Timing: Prior to initiation
Routine Monitoring
Frequency: Regularly, especially after dose adjustments (e.g., 1-2 weeks after initiation or change), then periodically (e.g., monthly to every 3-6 months) once stable.
Target: <130/80 mmHg (or individualized target based on comorbidities)
Action Threshold: Persistent hypotension (<90/60 mmHg) or uncontrolled hypertension (>140/90 mmHg) warrants dose adjustment or further evaluation.
Frequency: 1-2 weeks after initiation or dose increase, then periodically (e.g., every 3-6 months) or more frequently in patients with pre-existing renal impairment or on concomitant nephrotoxic drugs.
Target: Stable or within acceptable limits (e.g., Cr increase <30% from baseline)
Action Threshold: Acute increase in Cr >30% from baseline or significant decline in GFR warrants dose reduction, discontinuation, or investigation for renal artery stenosis.
Frequency: 1-2 weeks after initiation or dose increase, then periodically (e.g., every 3-6 months) or more frequently in patients at risk for hyperkalemia (e.g., renal impairment, diabetes, concomitant potassium-sparing diuretics/supplements).
Target: 3.5-5.0 mEq/L
Action Threshold: K+ >5.5 mEq/L warrants dose reduction, discontinuation, or intervention for hyperkalemia.
Frequency: Periodically, especially in patients with collagen vascular disease or on immunosuppressants.
Target: Normal cell counts
Action Threshold: Significant neutropenia or agranulocytosis warrants discontinuation.
Symptom Monitoring
- Angioedema (swelling of face, lips, tongue, glottis, larynx)
- Persistent dry cough
- Dizziness or lightheadedness (especially upon standing)
- Fatigue
- Signs of hyperkalemia (muscle weakness, irregular heartbeat)
- Signs of infection (fever, sore throat) - rare, but indicates neutropenia
Special Patient Groups
Pregnancy
Contraindicated during the second and third trimesters of pregnancy due to significant risk of fetal injury and death. Use in the first trimester is generally not recommended due to potential risks.
Trimester-Specific Risks:
Lactation
Perindoprilat is excreted in human milk. Due to the potential for serious adverse reactions in breastfed infants, a decision should be made whether to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.
Pediatric Use
Safety and effectiveness have not been established in pediatric patients. Use is generally not recommended.
Geriatric Use
No overall differences in effectiveness or safety have been observed between elderly and younger patients, but greater sensitivity of some older individuals cannot be ruled out. Start with lower doses (e.g., 2 mg once daily) and titrate carefully, especially considering potential for decreased renal function.
Clinical Information
Clinical Pearls
- Perindopril is a prodrug; its active metabolite is perindoprilat. Take it before meals for optimal absorption.
- A persistent dry cough is a common side effect of ACE inhibitors and may necessitate switching to an ARB.
- Monitor renal function and serum potassium closely, especially at initiation, with dose changes, or in patients with pre-existing renal impairment or on concomitant medications affecting potassium.
- Angioedema is a rare but potentially life-threatening side effect; educate patients on symptoms and to seek immediate medical attention.
- Avoid concomitant use with sacubitril/valsartan (Entresto) due to increased risk of angioedema; a 36-hour washout period is required.
- Perindopril is particularly effective in patients with stable coronary artery disease for reducing cardiovascular events.
Alternative Therapies
- Other ACE inhibitors (e.g., lisinopril, enalapril, ramipril)
- Angiotensin Receptor Blockers (ARBs) (e.g., valsartan, losartan, candesartan)
- Calcium Channel Blockers (CCBs)
- Thiazide diuretics
- Beta-blockers